[PP.22.16] APPLE POLIPHENOLS EFFECTS ON ENDOTHELIAL REACTIVITY AND SERUM URIC ACID: FROM PRECLINICAL DATA TO A DOUBLE BLIND-RANDOMIZED CLINICAL TRIAL. (September 2017)
- Record Type:
- Journal Article
- Title:
- [PP.22.16] APPLE POLIPHENOLS EFFECTS ON ENDOTHELIAL REACTIVITY AND SERUM URIC ACID: FROM PRECLINICAL DATA TO A DOUBLE BLIND-RANDOMIZED CLINICAL TRIAL. (September 2017)
- Main Title:
- [PP.22.16] APPLE POLIPHENOLS EFFECTS ON ENDOTHELIAL REACTIVITY AND SERUM URIC ACID
- Authors:
- A.F.G. Cicero,
Caliceti, C.
Fogacci, F.
Calabria, D.
Giovannini, M.
Rosticci, M.
Roda, A.
Borghi, C. - Abstract:
- Abstract : Objective: Several studies support a beneficial role of the dietary polyphenols in regulating some cardiovascular risk factors. The objective of our study was to examine the apple polyphenols' proprieties. Design and method: This was a two-phases study. The in vitro experiment was carried out developing a sensitive method measuring the intracellular xantine oxidase [XO] activity and its inhibition due to drugs effectively able to cross the cell membrane. A reaction mixture without XO was used as negative control and one with several diluition of oxypurinol was used as positive control. The in vivo study consisted in a randomized, double-blind, parallel placebo-controlled clinical trial involving 60 volunteers withsuboptimal values of fasting plasma glucose (101 mg/dL < FPG < 126 mg/dL). The treatment period was 8 weeks long and consisted in an indistinguishable pill of placebo or an active product, containing 300 mg of apple polyphenol extract. Results: The inhibition degree of XO by apple polyphenols was IC50 = 154 ± 28 ng/mL. During the clinical trial, after the first four weeks of treatment, the FPG decreased in the active treated group (−6, 1%, P < 0, 05), while no significant changes were observed in both groups of treatment regarding the other hematochemistry parameters or the blood pressure values and the anthropometric characteristics (P > 0, 05 always). After 8 weeks of treatment, the active-treated patients had an improvement in the FPG compared to theAbstract : Objective: Several studies support a beneficial role of the dietary polyphenols in regulating some cardiovascular risk factors. The objective of our study was to examine the apple polyphenols' proprieties. Design and method: This was a two-phases study. The in vitro experiment was carried out developing a sensitive method measuring the intracellular xantine oxidase [XO] activity and its inhibition due to drugs effectively able to cross the cell membrane. A reaction mixture without XO was used as negative control and one with several diluition of oxypurinol was used as positive control. The in vivo study consisted in a randomized, double-blind, parallel placebo-controlled clinical trial involving 60 volunteers withsuboptimal values of fasting plasma glucose (101 mg/dL < FPG < 126 mg/dL). The treatment period was 8 weeks long and consisted in an indistinguishable pill of placebo or an active product, containing 300 mg of apple polyphenol extract. Results: The inhibition degree of XO by apple polyphenols was IC50 = 154 ± 28 ng/mL. During the clinical trial, after the first four weeks of treatment, the FPG decreased in the active treated group (−6, 1%, P < 0, 05), while no significant changes were observed in both groups of treatment regarding the other hematochemistry parameters or the blood pressure values and the anthropometric characteristics (P > 0, 05 always). After 8 weeks of treatment, the active-treated patients had an improvement in the FPG compared to the baseline (−10, 3%, P < 0, 001) and the placebo group (P < 0, 001) and SUA significantly improved too (−14, 0%, P < 0, 05 vs baseline; P < 0, 05 vs placebo). Also the endothelial reactivity increased in the actively treated subjects in comparison with the baseline (0, 24 ± 0, 09, P = 0, 009) and the placebo-treated group (P < 0, 05). Conclusions: In vivo, apple polyphenols have a positive effect on the vascular oxidative stress and the endothelium function and reduce FPG and uric acid by the inhibition of the XO, as our in vitro experiment attests. … (more)
- Is Part Of:
- Journal of hypertension. Volume 35(2017)Supplement 2
- Journal:
- Journal of hypertension
- Issue:
- Volume 35(2017)Supplement 2
- Issue Display:
- Volume 35, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 35
- Issue:
- 2
- Issue Sort Value:
- 2017-0035-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-09
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://journals.lww.com/jhypertension/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004872-000000000-00000 ↗
http://www.jhypertension.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/01.hjh.0000523819.89904.a8 ↗
- Languages:
- English
- ISSNs:
- 1473-5598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5004.510000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4756.xml